Alcohol Use Disorders

The trajectory of sports gambling over the past several years exhibits strong ties to trends related to alcohol use disorders, results from a cross-sectional survey study showed.

SAN DIEGO — Glucagon-like peptide-1 receptor agonists may help alleviate risk for adverse liver outcomes, particularly hepatic decompensation, among patients with type 2 diabetes and alcohol-associated liver disease.

Individuals who develop type 1 diabetes during childhood experienced greater risk for several mental health conditions later in life, including anxiety disorders and substance use disorders, study results showed.

Individuals discharged from psychiatric inpatient care appeared vulnerable to premature death and suicidal behavior, according to a study published in JAMA Network Open.

Awakn Life Sciences Corp. has signed a licensing agreement with Revitalist Lifestyle and Wellness to implement its KARE protocol for those suffering from alcohol use disorder who are seeking sustained recovery and relapse prevention.

LONDON — Alcohol misuse was a primary trigger for progression of liver disease to hepatocellular carcinoma among a subset of French patients with type 2 diabetes, according to data presented at the International Liver Congress.

Independent risk factors for COVID-19 mortality included chronic liver disease and alcohol use disorders, which also contributed to disease burden in 2020, according to a presenter at the International Liver Congress.